Resumen de Role of the FDA in Affordability of Off-Patent Pharmaceuticals
Jeremy A. Greene, Gerard Anderson, Joshua M. Sharfstein
This Viewpoint maintains that the US Food and Drug Administration (FDA) should have a more active role in the approval and marketing of off-patent pharmaceutical products.
